A possible asymmetry at the checkpoint.

A possible asymmetry at the checkpoint. Transl Oncol. 2020 Jun 30;13(10):100821 Authors: Milano G Abstract A recently published systematic review and meta-analysis indicated that anti-PD-1 treatment may confer superior survival outcomes as compared to anti-PD-L1. We propose mechanistic explanations supporting this finding. PMID: 32619818 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32619818?dopt=Abstract

Source: Translational Oncology - June 29, 2020 Category: Cancer & Oncology Authors: Milano G Tags: Transl Oncol Source Type: research

More News: Cancer & Oncology